Global /South Korea /Healthcare /Drug Manufacturers - General /001630

Chong Kun Dang Holdings Corp.

001630

• KRX: 001630 • Delayed

49,350KRW -1%

32.51 USD

As of 17 June 2026, Chong Kun Dang Holdings Corp. has a market cap of $157.22M USD, ranking #22652 globally and #963 in South Korea. It ranks #2033 in the Healthcare sector, and #729 in the Drug Manufacturers - General industry.

Global Rank

22652

Country Rank

963

Sector Rank

2033

Industry Rank

729

Key Stats

Market Cap

$157.22MUSD

237.31B KRW

Enterprise Value

$617.29MUSD

937.05B KRW

Revenue (TTM)

$635.36MUSD

959.01B KRW

EBITDA (TTM)

$66.98MUSD

101.67B KRW

Net Income (TTM)

$26.79MUSD

40.43B KRW

EBITDA Margin

11%

Profit Margin

4.2%

PE Ratio

5.9

PS Ratio

0.2

PB Ratio

0.3

EV/EBITDA

9.2

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Hee-Nam Choi open_in_new

Employees

Founded

1941

Website

ckd-holdings.com/company/summary.do open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1%	-2.2%	-0.3%	-0.3%	5.4%	7.5%	7.6%	-2%	-56%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	001630 (주)종근당홀딩스 ISIN: KR7001630003 Shares Out.: Shares Outstanding: 4.761M¹ Shares Float: 2.235M² TV: TradingView: KRX: 001630 SA: Stock Analysis: KRX: 001630 YF: Yahoo Finance: 001630.KS GF: Google Finance: KRX: 001630 BA: Barron's: 001630 MS: Morningstar: XKRX: 001630	49,350 KRW	TV: TradingView: KRX: 001630 SA: Stock Analysis: KRX: 001630 YF: Yahoo Finance: 001630.KS GF: Google Finance: KRX: 001630 BA: Barron's: 001630 MS: Morningstar: XKRX: 001630

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Chong Kun Dang Holdings Corp.

Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. Chong Kun Dang Holdings Corp. was founded in 1941 and is based in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.22B 13.91T KRW 6K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.83B 10.3T KRW 4K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.28B 7.97T KRW 3K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$5.0B 7.55T KRW 3K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.58B 6.92T KRW 3K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.48B 6.76T KRW 3K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 484K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 348K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 229K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 205K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 184K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 175K%	20.5	Switzerland

chevron_leftBack